ScholarIQanswers from OpenAlex
Epworth Hospital
InstitutionResearch output, impact & collaborations
Epworth Hospital is a institution indexed in ScholarIQ from OpenAlex.
What is known about Epworth Hospital?
ScholarIQrecord summary
Epworth Hospital is a research organisation in Melbourne, AU. OpenAlex records 4,345 works and 263,054 citations for it. 816 researchers list it as their most recent affiliation.
How many works does Epworth Hospital have?
ScholarIQindexed works
Epworth Hospital has 4,345 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Epworth Hospital have?
ScholarIQcitation count
Epworth Hospital has 263,054 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Epworth Hospital?
ScholarIQresearcher count
Epworth Hospital has 816 researchers in the ScholarIQ index.
What is the average h-index at Epworth Hospital?
ScholarIQavg h-index
Epworth Hospital has an average h-index of 54 in OpenAlex.
What is the ROR of Epworth Hospital?
ScholarIQror
The ROR for Epworth Hospital is on the source record.
What is the OpenAlex record for Epworth Hospital?
ScholarIQopenalex
The OpenAlex for Epworth Hospital is on the source record.
Who are the most-cited researchers behind Epworth Hospital?
ScholarIQtop researchers by citations
What are the most-cited papers on Epworth Hospital?
ScholarIQmost cited works
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Dómine, Philip R. Clingan, Maximilian J. Hochmair, Steven Powell, Susanna Y. Cheng, Helge Bischoff, Nir Peled, Francesco Grossi, Ross Jennens, Martin Reck, Rina Hui, Edward B. Garon, Michael Boyer, Belén Rubio‐Viqueira, Silvia Novello, Takayasu Kurata, Jhanelle E. Gray, John Vida, Ziwen Wei, Jing Yang, Harry Raftopoulos, M. Catherine Pietanza, Marina Chiara Garassino
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer
Shirish M. Gadgeel, Delvys Rodríguez‐Abreu, Giovanna Speranza, Emilio Esteban, Enriqueta Felip, Manuel Dómine, Rina Hui, Maximilian J. Hochmair, Philip R. Clingan, Steven Powell, Susanna Y. Cheng, Helge Bischoff, Nir Peled, Francesco Grossi, Ross Jennens, Martin Reck, Edward B. Garon, Silvia Novello, Belén Rubio‐Viqueira, Michael Boyer, Takayasu Kurata, Jhanelle E. Gray, Jing Yang, Tuba Öcek Baş, M. Catherine Pietanza, Marina Chiara Garassino
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non–Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study
Marina Chiara Garassino, Shirish M. Gadgeel, Giovanna Speranza, Enriqueta Felip, Emilio Esteban, Manuel Dómine, Maximilian J. Hochmair, Steven Powell, Helge Bischoff, Nir Peled, Francesco Grossi, Ross Jennens, Martin Reck, Rina Hui, Edward B. Garon, Takayasu Kurata, Jhanelle E. Gray, Paul Schwarzenberger, Erin Jensen, M. Catherine Pietanza, Delvys Rodríguez‐Abreu
The American Congress of Rehabilitation Medicine Diagnostic Criteria for Mild Traumatic Brain Injury
Noah D. Silverberg, Grant L. Iverson, Alison M. Cogan, Kristen Dams-O’Connor, Richard Delmonico, Min Jeong P. Graf, Mary Alexis Iaccarino, Maria Kajankova, Joshua Kamins, Karen McCulloch, Gary McKinney, Drew Nagele, William J. Panenka, Amanda R. Rabinowitz, Nick Reed, Jennifer V. Wethe, Victoria C. Whitehair, Vicki Anderson, David B. Arciniegas, Mark Bayley, Jeffery J. Bazarian, Kathleen Bell, Steven P. Broglio, David X. Cifu, Gavin A Davis, Jiří Dvořák, Ruben J. Echemendía, Gérard A. Gioia, Christopher C. Giza, Sidney R. Hinds, Douglas I. Katz, Brad G. Kurowski, John J. Leddy, Natalie Le Sage, Angela Lumba‐Brown, Andrew IR Maas, Geoffrey T. Manley, Michael McCrea, David Menon, Jennie Ponsford, Margot Putukian, Stacy J. Suskauer, Joukje van der Naalt, William C. Walker, Keith Owen Yeates, Ross Zafonte, Nathan D. Zasler, Roger Zemek
How much of the research on Epworth Hospital is open access?
ScholarIQopen access share
100%OPEN ACCESS